Anti-Gonadotrophin Releasing Hormones

Initial 4-week prescription to be written by secondary care specialist. Thereafter the GP can prescribe on a rolling basis. The required DEXA scan monitoring outlined by the SPC, to be undertaken by the secondary care specialist.’ 

A dual X ray absorptiometry (DXA) scan is recommended after 1 year of treatment. In patients with risk factors for osteoporosis or bone loss, a DXA scan is recommended prior to starting Ryeqo treatment.’ ‘and as considered appropriate thereafter’.

‘Ryeqo can be taken without interruption. Discontinuation should be considered when the patient enters menopause, as the symptoms of both uterine fibroids and endometriosis are known to regress when menopause begins.